Investment firm which in backing biotech, offering investors the opportunity to back promising medical innovations via the EIS and SEIS.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2021 | Turbine | Series A | 0 |
1/2021 | Turbine | Seed Round | 7M |
2/2020 | Pencil Biosciences | Seed Round | - |
4/2021 | SomaServe | Series A | 0 |
6/2022 | Spirea Ltd. | Venture Round | 0 |
1/2021 | Spirea Ltd. | Seed Round | - |
2/2020 | Neurofenix | Seed Round | - |
7/2021 | Kuano | Seed Round | 1.4M |
11/2019 | Oxford Drug Design | Venture Round | 2.8M |
5/2022 | Oxford Drug Design | Convertible Note | 2.7M |
3/2019 | DeepMatter Group | Post-IPO Equity | - |
6/2020 | Qkine | Series A | 1.9M |
7/2022 | CardiaTec Biosciences | Pre Seed Round | 0 |
11/2019 | Turbine | Seed Round | 3.3M |
1/2019 | Exonate | Series A | 1.9M |
9/2017 | Absynth Biologics | Equity Crowdfunding | - |
5/2018 | Stemnovate | Seed Round | - |
9/2021 | Sanome | Pre Seed Round | 0 |
4/2019 | Metrion Biosciences | Series A | - |
7/2019 | SomaServe | Seed Round | - |
5/2023 | PharmEnable | Seed Round | 0 |
3/2021 | PhoreMost | Series B | 45.3M |
7/2022 | CardiaTec Biosciences | Pre Seed Round | 0 |
6/2022 | Spirea Ltd. | Venture Round | 0 |
5/2022 | Oxford Drug Design | Convertible Note | 0 |
9/2021 | Sanome | Pre Seed Round | 0 |
7/2021 | Kuano | Seed Round | 0 |
4/2021 | SomaServe | Series A | 0 |
3/2021 | PhoreMost | Series B | 0 |
1/2021 | Spirea Ltd. | Seed Round | - |
1/2021 | Turbine | Series A | 0 |
6/2020 | Qkine | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|